Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

LKB1/AMPK/mTOR signaling pathway in non-small-cell lung cancer.

Han D, Li SJ, Zhu YT, Liu L, Li MX.

Asian Pac J Cancer Prev. 2013;14(7):4033-9. Review.

PMID:
23991948
[PubMed - indexed for MEDLINE]
Free Article
2.

Inhibition of p53 attenuates steatosis and liver injury in a mouse model of non-alcoholic fatty liver disease.

Derdak Z, Villegas KA, Harb R, Wu AM, Sousa A, Wands JR.

J Hepatol. 2013 Apr;58(4):785-91. doi: 10.1016/j.jhep.2012.11.042. Epub 2012 Dec 2.

PMID:
23211317
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

The LKB1-AMPK pathway: metabolism and growth control in tumour suppression.

Shackelford DB, Shaw RJ.

Nat Rev Cancer. 2009 Aug;9(8):563-75. doi: 10.1038/nrc2676.

PMID:
19629071
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk